NCT02919683 2026-01-28Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral CavityDana-Farber Cancer InstitutePhase 2 Active not recruiting30 enrolled 14 charts
NCT02812524 2025-03-10Ipilimumab for Head and Neck Cancer PatientsProvidence Health & ServicesPhase 1 Active not recruiting18 enrolled